Long-Term Prognosis of Coronary Aneurysms Insights of CAAR, an International Registry

Authors

SANCHEZ-SANCHEZ Ivan CERRATO Enrico BOLLATI Mario ESPEJO-PAERES Carolina NOMBELA-FRANCO Luis ALFONSO-RODRIGUEZ Emilio CAMACHO-FREIRE Santiago J VILLABLANCA Pedro A AMAT-SANTOS Ignacio J HERNANDEZ Jose M De la Torre PASCUAL Isaac LIEBETRAU Christoph CAMACHO Benjamin PAVANI Marco ALBISTUR Juan LATINI Roberto Adriano VARBELLA Ferdinando DIAZ Victor Alfonso Jimenez PIRAINO Davide MANCONE Massimo ALFONSO Fernando LINARES Jose Antonio RODRIGUEZ-OLIVARES Ramon JIMENEZ-MAZUECOS Jesus M MOLINERO Jorge Palazuelos FLECHA Alejandro Sanchez-Grande GOMEZ-HOSPITAL Joan Antoni IELASI Alfonso LOZANO Inigo OMEDE Pierluigi FELTES Gisela UGO Fabrizio MEDDA Massimo RAMAKRISHNA Harish KALA Petr BAUTISTA Daniel ALKHOULI Mohamad FERNANDEZ-ORTIZ Antonio NUNEZ-GIL Ivan J

Year of publication 2024
Type Article in Periodical
Magazine / Source JACC - Cardiovascular Interventions
MU Faculty or unit

Faculty of Medicine

Citation
web https://linkinghub.elsevier.com/retrieve/pii/S1936879824011543
Doi http://dx.doi.org/10.1016/j.jcin.2024.08.034
Keywords acute coronary syndrome(s); aneurysm complications; coronary aneurysm; coronary artery disease; coronary ectasia
Description BACKGROUND Limited data are available to guide the management of coronary artery aneurysms (CAAs). OBJECTIVES The authors sought to define the clinical characteristics, identify variables that predict outcomes, and provide long-term data on CAAs. METHODS We describe outcomes from 1,729 consecutive patients with CAAs included in an ambispective international registry (CAAR [Coronary Artery Aneurysm Registry]; NCT02563626) involving 33 hospitals across 9 countries in America and Europe. RESULTS Patients were predominantly male (78.6%; 1,359/1,729) with a mean age of 66 years. Classic cardiovascular risk factors were common, as well as coronary artery disease (85.8%; 1,484/1,729), peripheral vascular disease (10.9%; 188/1,729), and chronic kidney disease (8.0%; 138/1,729). The median number of aneurysms per patient was 1.0 (Q1-Q3: 1.0-1.0), with the most affected territory being the left anterior descending artery (49.6%; 857/1,729). The majority underwent any revascularization procedure (68.5%; 1,184/1,729), mainly percutaneous coronary intervention (50.7%; 877/1,729), and were discharged on dual antiplatelet therapy (65.6%; 1,134/1,729). After a median follow-up of 44.8 months (Q1-Q3: 14.9-88.1), 379 died (21.9%), and 641 (37.1%) developed a major adverse cardiovascular event (MACE) (all-cause death, heart failure, unstable angina, and reinfarction). In a multivariable analysis, age (HR: 1.03; 95% CI: 1.02-1.04; P < 0.001), diabetes mellitus (HR: 1.47; 95% CI: 1.23-1.75; P < 0.001), renal insufficiency (HR: 1.53; 95% CI: 1.19-1.96; P = 0.010), peripheral vessel disease (HR: 1.43; 95% CI: 1.13-1.82; P = 0.003), reduced left ventricular ejection fraction (HR: 0.98; 95% CI: 0.98-0.99; P < 0.001), acute indication for the index coronary angiography (HR: 1.30; 95% CI: 1.08-1.55; P = 0.005), and the number of coronary vessels presenting severe stenosis (HR: 1.11; 95% CI: 1.02-1.20; P = 0.015) were independent predictors of MACEs. Remarkably, only 37 patients presented with local aneurysm complications during follow-up. CONCLUSIONS The long-term prognosis of CAAs is not favorable, with MACEs associated with the underlying risk factor profile for atherosclerotic heart disease. (JACC Cardiovasc Interv. 2024;17:2681-2691) (c) 2024 by the American College of Cardiology Foundation.

You are running an old browser version. We recommend updating your browser to its latest version.

More info